• Explore /
  • Poster
  • / Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer.

Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer.

Abstract Poster

Authors

null

Ralph Zinner

University of Kentucky, Department of Medical Oncology, Lexington, KY

Ralph Zinner , Jennifer M Johnson , Madalina Tuluc , Joseph M. Curry , Adam Luginbuhl , Christopher C Fundakowski , Andrew Yampolsky , Richard A Goldman , Charalambos C Solomides , Stacey Mardekian , Catherine Tucker , D. Craig Hooper , Larry Harshyne , Dorit Arditti-Falk , Dawn Poller , Benjamin Leiby , Voichita C Bar-Ad , Rita Axelrod , Athanassios Argiris , David M. Cognetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03342911

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6583)

DOI

10.1200/JCO.2020.38.15_suppl.6583

Abstract #

6583

Poster Bd #

244

Abstract Disclosures

Similar Posters

First Author: Kevin Joseph Harrington

First Author: Adam Luginbuhl

First Author: Yara L. Verschoor

First Author: Richard Francis Dunne